Navigation Links
Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology
Date:8/30/2010

ROCKVILLE, Md., Aug. 30 /PRNewswire/ -- Sequella, Inc., a clinical-stage company focused on commercialization of novel drugs for life-threatening infectious diseases, announced today the restatement of its exclusive international license agreement with the University of Maryland, Baltimore (UMB), concerning certain technology related to monitoring drug therapy compliance.  The issued technology patent (U.S. 6,663,846), jointly owned by Sequella and UMB, addresses transdermal detection of a labeled pill to monitor drug compliance. Non-compliance with drug regimens contributes $290 billion in annual costs to the United States healthcare system.

"With recent technological advances, the market for drug compliance monitoring represents a tremendous opportunity for many pharmaceutical industry sectors, including those concerned with drug compliance, manufacturing, anti-counterfeiting, and clinical trial conduct," said Sequella CEO, Carol Nacy.  "We are pleased to strengthen our relationship with UMB to enhance development and marketing of our assets."

Sequella's Event Marker System (EMS) for transdermal drug compliance monitoring uses a wristwatch device to detect labeled pills.  

"Our exclusive license agreement with UMB is a classic win-win for both parties," said Alan Klein, Executive Vice President of Corporate Development for Sequella. "We look forward to playing a key role in the rapidly expanding marketplace for drug compliance monitoring."

"We are delighted to continue this relationship with Sequella to bring this exciting technology to market," said James L. Hughes, Vice President, Research and Development, University of Maryland.

About the Technology

The '846 patent includes "a method for monitoring drug therapy compliance, by human or animal patient, comprising contacting the patient with a transdermal detection device capable of receiving a signal from a labeled pill administered to the patient
'/>"/>

SOURCE Sequella, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sequella Receives American Recovery and Reinvestment Funding Through the NIH
2. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
3. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
4. Siteman Cancer Center at Barnes-Jewish and Washington University to Receive First ViewRay Radiation Therapy System
5. Bayer HealthCare Pharmaceuticals Supports New Jersey Governors School in the Sciences at Drew University
6. SRI International and Stanford University School of Medicines MISTRAL Collaborative and the Institute for Pediatric Innovation Awarded FDA Grant to Accelerate Commercialization of Pediatric Medical Devices
7. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
8. University of Luebeck Joins GeneGos Metaminer Cardiac Project
9. University HealthSystem Consortium Awards Single-Source Agreement to Ascent for Medical Device Reprocessing Services
10. Biospherics Acquires Global Patent Rights from University of Kentucky Research Foundation to Develop Tagatose as a Trigylcerides Therapy
11. Ethicon Endo-Surgery Extends Research Partnership with $13.5 Million Grant to University of Cincinnati
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
(Date:1/23/2015)... South Africa , Jan. 23, 2015   Leatt ... of personal protective equipment for all forms of sports, ... flagship Leatt-Brace® neck brace, announced today that the UISP ... federation, now requires all riders to wear a neck ...
(Date:1/23/2015)... and BOSTON , January 23, ... drug discovery and development company, is delighted to announce that ... been awarded to Miles Congreve (Vice President of ... and Malcolm Weir (Chief Executive Officer and co-founder) ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... Calif., Oct. 29 Beckman Coulter, Inc. (NYSE: ... products that simplify, automate and innovate complex biomedical testing, ... 30, 2009 results. Reported third quarter revenue, including ... million, up 8.4% over prior year quarter, or 11.6% ...
... season, settle your stomach, relieve your wallet , YONKERS, ... many of us may suffer from occasional heartburn, a new Best ... you probably don,t need an expensive drug like Nexium, the "purple ... effectiveness research to identify "Best Buys" based on safety, effectiveness, and ...
Cached Medicine Technology:Beckman Coulter Announces Third Quarter 2009 Results 2Beckman Coulter Announces Third Quarter 2009 Results 3Beckman Coulter Announces Third Quarter 2009 Results 4Beckman Coulter Announces Third Quarter 2009 Results 5Beckman Coulter Announces Third Quarter 2009 Results 6Beckman Coulter Announces Third Quarter 2009 Results 7Beckman Coulter Announces Third Quarter 2009 Results 8Beckman Coulter Announces Third Quarter 2009 Results 9Beckman Coulter Announces Third Quarter 2009 Results 10Beckman Coulter Announces Third Quarter 2009 Results 11Beckman Coulter Announces Third Quarter 2009 Results 12Beckman Coulter Announces Third Quarter 2009 Results 13Beckman Coulter Announces Third Quarter 2009 Results 14Beckman Coulter Announces Third Quarter 2009 Results 15Beckman Coulter Announces Third Quarter 2009 Results 16Beckman Coulter Announces Third Quarter 2009 Results 17Beckman Coulter Announces Third Quarter 2009 Results 18Beckman Coulter Announces Third Quarter 2009 Results 19Beckman Coulter Announces Third Quarter 2009 Results 20Beckman Coulter Announces Third Quarter 2009 Results 21Beckman Coulter Announces Third Quarter 2009 Results 22Beckman Coulter Announces Third Quarter 2009 Results 23Beckman Coulter Announces Third Quarter 2009 Results 24Beckman Coulter Announces Third Quarter 2009 Results 25Beckman Coulter Announces Third Quarter 2009 Results 26Beckman Coulter Announces Third Quarter 2009 Results 27Beckman Coulter Announces Third Quarter 2009 Results 28Beckman Coulter Announces Third Quarter 2009 Results 29Beckman Coulter Announces Third Quarter 2009 Results 30Beckman Coulter Announces Third Quarter 2009 Results 31Beckman Coulter Announces Third Quarter 2009 Results 32Beckman Coulter Announces Third Quarter 2009 Results 33Consumer Reports Health: Americans With Heartburn Paying Too Much Green For Nexium's 'Purple Pill' 2Consumer Reports Health: Americans With Heartburn Paying Too Much Green For Nexium's 'Purple Pill' 3
(Date:1/22/2015)... 22, 2015 Woodloch Pines, an all-inclusive ... selected by TripAdvisor as the number one best large hotel ... in the world for their annual Travelers’ Choice Awards. ... . The website is home to millions of unbiased and ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader ... designers are thrilled to have it lead the wedding dress ... collection of prom dresses for the global market. , “The ... vision and he focuses on continuing the goal of operational ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Blue Cross and ... Minnesotans who exemplify what it means to “Live Fearless.” ... for people to share their stories about how they or ... simply inspired others by living in the moment. By telling ...
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
(Date:1/22/2015)... 2015 Autocarinsurancebest.com has released a new blog ... auto insurance policy . , Auto insurance quotes help ... is no longer necessary to call an agent or visit ... online on a single website: http://autocarinsurancebest.com/ . , Every ...
Breaking Medicine News(10 mins):Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2
... 3 Targeted Genetics Corporation,(Nasdaq: TGEN ) ... (NIH),Recombinant DNA Advisory Committee,s (RAC) assessment of the ... Phase I/II trial of,tgAAC94 for inflammatory arthritis., ... was a result of,complications from an opportunistic infection, ...
... ALBANY, N.Y., Dec. 3 AARP recently ... the state to,address three major issues that impact ... New Yorkers: prescription drug marketing reform and,affordability, housing ... are critical issues that help New Yorkers stay ...
... Dec. 3 Coherent, Inc.,(Nasdaq: COHR ) today ... of the Board of Directors of The Nasdaq Stock ... file its past due periodic reports,for the year ended ... 2007 with the Securities Exchange Commission ("SEC") in order ...
... ORLANDO, Fla., Dec. 3 A new study ... depressant effects in,patients (40 years and older) with ... measured by oxygenation or abnormal breathing,events relative to ... at the 53rd International,Respiratory Congress of the American ...
... that protect cells from the powerful, common chemotherapeutic agent ... how the drug also can destroy the heart., We ... for cell survival in the face of doxorubicin, says ... of Georgia Cancer Center. At the moment you start ...
... to lead can hinder the brains ability to recover ... The results have implications for the effects of environmental ... researchers at Jefferson Medical College, who led the work. ... increase the risk for cancer, renal disease, hypertension and ...
Cached Medicine News:Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 2Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 3Health News:Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Assessment of Its Phase I/II Trial of tgAAC94 for Inflammatory Arthritis 4Health News:AARP Urges Governor to Use Budget to Improve New Yorkers' Quality of Life 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 2Health News:Coherent, Inc. Reports Decision by the Nasdaq Stock Market 3Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 2Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 3Health News:New Study Demonstrates Ramelteon Does Not Exacerbate Respiratory Depressant Effects in Patients With Moderate-to-Severe COPD 4Health News:Genes identified that protect against heart damage from chemotherapy 2Health News:Jefferson neuroscientists find early lead exposure impedes recovery from brain injury 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: